Asterion Cannabis Inc.

Recent News

  • Asterion Cannabis Announces Annual General Meeting Results and Election of New Director

    Vancouver, British Columbia--(Newsfile Corp. - January 27, 2020) - Asterion Cannabis Inc. ("Asterion" or the "Company"), is pleased to announce the voting results from the Company's 2020 annual general meeting of shareholders (the "Meeting") held on Friday, January 24, 2020, in Vancouver, British Columbia. A total of 45,613,167 common ...

    2020-01-27 8:00 AM ET
  • Asterion to Hold 2020 Annual General Meeting

    Vancouver, British Columbia--(Newsfile Corp. - January 14, 2020) - Asterion Cannabis Inc. ("Asterion" or the "Company") announces that the Company's 2020 Annual General Meeting of Shareholders ("AGM") will be held on Friday, January 24, 2020 at 10:00 a.m. Pacific Time at Suite 2200 - 1177 West Hastings Street, Vancouver, ...

    2020-01-14 12:34 PM ET
  • Asterion Announces $10 Million Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - January 2, 2020) - Asterion Cannabis Inc. ("Asterion" or the "Company"), announces a non-brokered private placement of up to 6,666,667 units (each, a "Unit") at the price of CAD $1.50 per Unit, for aggregate gross proceeds of up to CAD $10,000,000 (the "Financing"). ...

    2020-01-02 9:00 AM ET
  • Asterion Awarded Medicinal Cannabis Licences from the Australian Office of Drug Control

    Vancouver, British Columbia--(Newsfile Corp. - December 23, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company"), announces that its wholly-owned Australian subsidiary ("Asterion Australia") has received its licences for the cultivation, manufacturing and research of medicinal cannabis (the "Licences") from the Australian Government's Office of Drug Control ("ODC"), effective December ...

    2019-12-23 8:00 AM ET
  • Asterion Lodges Operational Works Permit Application for Development at its Medicinal Cannabis Propagation and Processing Facility

    Vancouver, British Columbia--(Newsfile Corp. - November 12, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company") announces that the Company's wholly-owned Australian subsidiary ("Asterion Australia") has submitted its Operational Works permit (the "Operational Works Permit") application to the Toowoomba Regional Council (the "Council") to seek approval of certain development activities ...

    2019-11-12 9:00 AM ET
  • Asterion Receives Development Approval Permit for its Medicinal Cannabis Propagation and Processing Facility

    Vancouver, British Columbia--(Newsfile Corp. - November 6, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company") announces that the Company's wholly-owned Australian subsidiary ("Asterion Australia") has received the required Development Approval ("DA") permit from the Toowoomba Regional Council (the "Council") for the Company's Toowoomba Medicinal Cannabis Project (the "Project"). The ...

    2019-11-06 3:31 PM ET
  • Asterion Announces Appointment of Mr. Peter Ryan as Director of Development (Australia)

    Vancouver, British Columbia--(Newsfile Corp. - August 26, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company"), announces the appointment of Mr. Peter Ryan, PhD, BEng, BBus, MProMan, as the Director of Development (Australia).Mr. Ryan is an executive engineer and business leader with a track record of delivering strong operational ...

    2019-08-26 10:20 AM ET
  • PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property

    Vancouver, British Columbia--(Newsfile Corp. - August 6, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), and Asterion Cannabis Inc. ("Asterion") announce that they have entered into an option to purchase agreement (the "Option Agreement"), whereby PreveCeutical has granted to Asterion the right and option (the "Option") ...

    2019-08-06 2:16 PM ET